or Try an Advanced Search...

    Technical Analysis for DSGN - Design Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 5.20 -0.76% -0.04
    DSGN closed down 0.76 percent on Friday, November 1, 2024, on 27 percent of normal volume. It ran into resistance at its 50 day moving average.
    Earnings due: Nov 11
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical DSGN trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Fell Below 20 DMA Bearish -0.76%
    Fell Below 50 DMA Bearish -0.76%
    MACD Bearish Signal Line Cross Bearish -0.76%
    180 Bearish Setup Bearish Swing Setup -0.76%
    Outside Day Range Expansion -0.76%
    Bullish Engulfing Bullish -6.64%
    Wide Bands Range Expansion -6.64%
    20 DMA Support Bullish -3.88%
    50 DMA Support Bullish -3.88%
    Older End-of-Day Signals for DSGN ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 18 hours ago
    Down 2 % about 18 hours ago
    Down 1% about 19 hours ago
    Possible NR7 about 19 hours ago
    60 Minute Opening Range Breakdown about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DSGN Chart by TradingView
    Basic chart:

    Profile

    Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders

    Is DSGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 26 Pleasing Signs As A Number Of Insiders Buy Design Therapeutics Stock
    Sep 10 Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
    Aug 21 Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet
    Aug 16 With 34% ownership, Design Therapeutics, Inc. (NASDAQ:DSGN) has piqued the interest of institutional investors
    Aug 5 Design Therapeutics GAAP EPS of -$0.21
    Aug 5 Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
    May 23 The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    May 10 Design Therapeutics Inc (DSGN) Q1 2024 Earnings: A Detailed Financial and Strategic Review
    May 9 Design Therapeutics GAAP EPS of -$0.20
    May 8 Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
    See more DSGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.91
    52 Week Low 1.96
    Average Volume 257,447
    200-Day Moving Average 4.03
    50-Day Moving Average 5.25
    20-Day Moving Average 5.32
    10-Day Moving Average 5.47
    Average True Range 0.36
    RSI (14) 47.09
    ADX 20.5
    +DI 21.45
    -DI 19.02
    Chandelier Exit (Long, 3 ATRs) 4.95
    Chandelier Exit (Short, 3 ATRs) 5.56
    Upper Bollinger Bands 6.07
    Lower Bollinger Band 4.56
    Percent B (%b) 0.42
    BandWidth 28.43
    MACD Line 0.06
    MACD Signal Line 0.09
    MACD Histogram -0.0332
    Fundamentals Value
    Market Cap 291.21 Million
    Num Shares 56 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -4.03
    Price-to-Sales 22642.01
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.58
    Resistance 3 (R3) 5.57 5.43 5.51
    Resistance 2 (R2) 5.43 5.34 5.44 5.49
    Resistance 1 (R1) 5.32 5.28 5.25 5.33 5.47
    Pivot Point 5.18 5.18 5.15 5.19 5.18
    Support 1 (S1) 5.07 5.09 5.00 5.08 4.93
    Support 2 (S2) 4.93 5.03 4.94 4.91
    Support 3 (S3) 4.82 4.93 4.89
    Support 4 (S4) 4.83